Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Sep;14(3):420–435. doi: 10.1128/aac.14.3.420

Antimalarial Activities of Various 4-Pyridinemethanols with Special Attention to WR-172,435 and WR-180,409†

L H Schmidt 1, Ruth Crosby 1, Jane Rasco 1, Dennis Vaughan 1
PMCID: PMC352475  PMID: 101132

Abstract

Pilot appraisals of the activities of 10 specially selected 2,6-substituted-4-pyridinemethanols against acute Plasmodium falciparum infections in owl monkeys identified three derivatives that were two to three times as active as chloroquine against infections with a 4-aminoquinoline-susceptible strain and, at the same doses, were equally effective against infections with a strain fully resistant to treatment with maximally tolerated doses of chloroquine, quinine, and pyrimethamine. Two of these derivatives, WR-172,435 and WR-180,409, deemed worthy of evaluation in human volunteers, were studied in greater depth in owl monkeys infected with either the multidrug-resistant Smith strain of P. falciparum or the pyrimethamine-resistant Palo Alto strain of P. vivax. These studies showed (i) that at the same total oral dose, 3-day and 7-day treatment schedules were equally effective and slightly superior to a single-dose schedule; (ii) that WR-172,435 was slightly more active than WR-180,409 in each treatment regimen; (iii) that intravenous delivery of WR-180,409 phosphate was feasible and effective; (iv) that both compounds effected control of parasitemia more rapidly than any standard or newly discovered antimalarial drug; and (v) that WR-172,435 and WR-180,409 had therapeutic indexes at least four to eight times those exhibited by chloroquine in infections with 4-aminoquinoline-susceptible strains, indexes retained by these pyridinemethanols against infections with various drug-resistant strains.

Full text

PDF
420

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold J. D., Martin D. C., Carson P. E., Rieckmann K. H., Willerson D., Jr, Clyde D. F., Miller R. M. A phenanthrene methanol (WR 33063) for treatment of acute malaria. Antimicrob Agents Chemother. 1973 Feb;3(2):207–213. doi: 10.1128/aac.3.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blumbergs P., LaMontagne M. P., Markovac A., Moehring J. G., Ash A. B., Stevens C. L. Antimalarials. 2. 2,6-Bis(aryl)-4-pyridinemethanols. J Med Chem. 1972 Aug;15(8):808–812. doi: 10.1021/jm00278a006. [DOI] [PubMed] [Google Scholar]
  3. Colwell W. T., Brown V., Christie P., Lange J., Reece C., Yamamoto K., Henry D. W. Antimalarial arylaminopropanols. J Med Chem. 1972 Jul;15(7):771–775. doi: 10.1021/jm00277a018. [DOI] [PubMed] [Google Scholar]
  4. Hall A. P. The treatment of malaria. Br Med J. 1976 Feb 7;1(6005):323–328. doi: 10.1136/bmj.1.6005.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LaMontagne M. P., Markovac A., Ao M. S. Antimalarials. 5. 2-Aryl-6-trifluoromethyl-4-pyridinemethanols. J Med Chem. 1973 Sep;16(9):1040–1041. doi: 10.1021/jm00267a018. [DOI] [PubMed] [Google Scholar]
  6. LaMontagne M. P., Markovac A., Blumbergs P. Antimalarials. 6. Synthesis, antimalarial activity, and configurations of racemic alpha-(2-piperidyl)-4-pyridinemethanols. J Med Chem. 1974 May;17(5):519–523. doi: 10.1021/jm00251a010. [DOI] [PubMed] [Google Scholar]
  7. Markovac A., LaMontagne M. P., Blumbergs P., Ash A. B., Stevens C. L. Antimalarials. 3. 2,6-Bis(aryl)-4-pyridinemethanols with trifluoromethyl substituents. J Med Chem. 1972 Sep;15(9):918–922. doi: 10.1021/jm00279a010. [DOI] [PubMed] [Google Scholar]
  8. Martin D. C., Arnold J. D., Clyde D. F., al-Ibrahim M., Carson P. E., Rieckmann K. H., Willerson D., Jr A quinoline methanol (WR 30090) for treatment of acute malaria. Antimicrob Agents Chemother. 1973 Feb;3(2):214–219. doi: 10.1128/aac.3.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pullman T. N., Eichelberger L., Alving A. S., Jones R., Craige B., Whorton C. M. THE USE OF SN-10,275 IN THE PROPHYLAXIS AND TREATMENT OF SPOROZOITE-INDUCED VIV AX MALARIA (CHESSON STRAIN). J Clin Invest. 1948 May;27(3 Pt 2):12–16. doi: 10.1172/JCI101949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rinehart J., Arnold J., Canfield C. J. Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669. Am J Trop Med Hyg. 1976 Nov;25(6):769–774. doi: 10.4269/ajtmh.1976.25.769. [DOI] [PubMed] [Google Scholar]
  11. Rothe W. E., Jacobus D. P. Laboratory evaluation of the phototoxic potency of quinolinemethanols. J Med Chem. 1968 Mar;11(2):366–368. doi: 10.1021/jm00308a041. [DOI] [PubMed] [Google Scholar]
  12. Ruiz R., Belej M., Aviado D. M. Cardiopulmonary effects of antimalarial drugs. II. Phenanthrenemethanols. Toxicol Appl Pharmacol. 1970 Jul;17(1):118–129. doi: 10.1016/0041-008x(70)90137-7. [DOI] [PubMed] [Google Scholar]
  13. SCHMIDT L. H., GENTHER C. S. The antimalarial properties of 2, 4-diamino-5-p-chlorophenyl-6-ethylpyrimidine, daraprim. J Pharmacol Exp Ther. 1953 Jan;107(1):61–91. [PubMed] [Google Scholar]
  14. Schmidt L. H., Crosby R., Rasco J., Vaughan D. Antimalarial activities of various 4-quinolonemethanols with special attention to WR-142,490 (mefloquine). Antimicrob Agents Chemother. 1978 Jun;13(6):1011–1030. doi: 10.1128/aac.13.6.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schmidt L. H. Infections with Plasmodium falciparum and Plasmodium vivax in the owl monkey--model systems for basic biological and chemotherapeutic studies. Trans R Soc Trop Med Hyg. 1973;67(4):446–474. doi: 10.1016/0035-9203(73)90077-1. [DOI] [PubMed] [Google Scholar]
  16. Schmidt L. H. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). I. The courses of untreated infections. Am J Trop Med Hyg. 1978 Jul;27(4):671–702. doi: 10.4269/ajtmh.1978.27.671. [DOI] [PubMed] [Google Scholar]
  17. Schmidt L. H. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). II. Responses to chloroquine, quinine, and pyrimethamine. Am J Trop Med Hyg. 1978 Jul;27(4):703–717. doi: 10.4269/ajtmh.1978.27.703. [DOI] [PubMed] [Google Scholar]
  18. Schmidt L. H. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). III. Methods employed in the search for new blood schizonticidal drugs. Am J Trop Med Hyg. 1978 Jul;27(4):718–737. doi: 10.4269/ajtmh.1978.27.718. [DOI] [PubMed] [Google Scholar]
  19. Trenholme C. M., Williams R. L., Desjardins R. E., Frischer H., Carson P. E., Rieckmann K. H., Canfield C. J. Mefloquine (WR 142,490) in the treatment of human malaria. Science. 1975 Nov 21;190(4216):792–794. doi: 10.1126/science.1105787. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES